Polymorphisms in STAT4 increase the risk of acute renal allograft rejection in the Chinese population

Transplant Immunology

Volumn 24, Issue 4, 2011, Pages 216-219

  Yang, H ^a,b   Zhou, Q ^a,b   Chen, Z M ^a,b   Chen, W Q ^a,b   Wang, M M ^a,b   Chen, J H ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b State Administration of Traditional Chinese Medicine of the People's Republic of China   (China)

Author keywords

Acute allograft rejection; Gene polymorphisms; STAT4

Indexed keywords

CYCLOSPORIN; GENOMIC DNA; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STAT4 PROTEIN; TACROLIMUS;

ADULT; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAFT RECIPIENT; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADULT; CASE-CONTROL STUDIES; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 79955440411     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2011.01.001     Document Type: Article

References (23)

1. Xin Lu D.L.P. A systems biology view of allograft rejection. Curr Opin Organ Transpl 2005, 10:28-34.
2. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 2007, 13:455.
3. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977.
4. Korman B.D., Alba M.I., Le J.M., Alevizos I., Smith J.A., Nikolov N.P., et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun 2008, 9:267-270.
5. Horvath C.M. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000, 25(10):496-502.
6. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004, 202:139-156.
7. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., et al. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis Rheum 2008, 58:1940-1946.
8. Lee H.S., Remmers E.F., Le J.M., Kastner D.L., Bae S.C., Gregersen P.K. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 2007, 13:455-460.
9. Orozco G., Alizadeh B.Z., Delgado-Vega A.M., Gonzalez-Gay M.A., Balsa A. Pascual- Salcedo D, et al. Association of STAT4 with rheumatoid arthritis: A replication study in three European populations. Arthritis Rheum 2008, 58:1974-1980.
10. Wu J.Y., Chen J.H., Wang Y.M., He Q. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplantation 2004, 78:713-718.
11. Racusen L.C., Colvin R.B., Solez K. Antibody-mediated rejection-an addition to the Banff classification of renal allograft rejection. Am J Transplant 2003, 3:708-714.
12. Valujskikh A., Baldwin W.M., Fairchild R.L. Progress and New Perspectives in Studying T Cell Responses to Allografts. Am J Transplant 2010, 10:1117-1125.
13. Atalar Kerem, Afzali Behdad, Lord Graham, Lombardi Giovanna Relative roles of Th1 and Th17 effector cells in allograft rejection. Curr Opin Organ Transpl 2009, 14:23-29.
14. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
15. Mcgeachy M., Cua D. Th17 cell differentiation: the long and winding road. Immunity 2008, 28:445-453.
16. Leon F., Smythies L.E., Smith P.D., Kelsall B.L. Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease. Adv Exp Med Biol 2006, 579:117-132.
17. Mathur A.N., Chang H.C., Zisoulis D.G., Stritesky G.L., Yu Q., O'Malley J.T., et al. STAT3 and STAT4 direct development of IL-17-secreting Th cells. J Immunol 2007, 178:4901-4907.
18. Goriely S., Goldman M. Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant 2008, 13:4-9.
19. Kawasaki A., Ito I., Hikami K., Ohashi J., Hayashi T., Goto D., et al. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res Ther 2008, 10:R113.
20. Koglin J., Glysing-Jensen T., Gadiraju S., Russell M.E. Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor STAT4. Circulation 2000, 101:1034-1039.
21. Zhou P., Szot G.L., Guo Z., Kim O., He G., Wang J., et al. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. J Immunol 2000, 165:5580-5587.
22. Trivedi H.L. Immunobiology of rejection and adaptation. Transplant Proc 2007, 39:647-652.
23. Stegall M.D., Dean P.G., Gloor J. Mechanisms of alloantibody production in sensitized renal allograft recipients. Am J Transplant 2009, 9:998-1005.